MARKET

EBS

EBS

Emergent Biosolutions Inc
NYSE
6.55
-0.25
-3.68%
After Hours: 6.55 0 0.00% 19:55 09/21 EDT
OPEN
6.80
PREV CLOSE
6.80
HIGH
6.90
LOW
6.48
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
14.06
52 WEEK LOW
4.360
MARKET CAP
335.84M
P/E (TTM)
-1.8663
1D
5D
1M
3M
1Y
5Y
1D
Emergent: The MCM Engine Runs, But Naloxone Is Breaking Down
Seeking Alpha · 6d ago
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
Barchart · 09/15 06:45
Emergent BioSolutions restructuring includes 90 job cuts
Seeking Alpha · 09/14 21:26
Emergent Biosolutions Highlights Global Public Health Countermeasures
TipRanks · 09/14 20:36
Weekly Report: what happened at EBS last week (0907-0911)?
Weekly Report · 09/14 09:52
Buy Rating Reaffirmed on Emergent’s Strengthened Government Contracts and Liquidity, Price Target Unchanged at $10
TipRanks · 09/09 10:55
Weekly Report: what happened at EBS last week (0831-0904)?
Weekly Report · 09/07 09:48
Emergent BioSolutions - Tough 2026 Outlook Warrant Rating Downgrade
Seeking Alpha · 09/06 17:25
More
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Webull offers Emergent Biosolutions Inc stock information, including NYSE: EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EBS stock methods without spending real money on the virtual paper trading platform.